Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Georg Hess, Simon Rule, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig, Isabelle Bence-Bruckler, Seok-Goo Cho, Wenjiong Zhou, Jenna D. Goldberg, Cristina Trambitas, Christopher Enny, Jessica Vermeulen, Shana Traina, Chiun-Fang Chiou, Joris Diels & Martin Dreyling. (2017) Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus. Leukemia & Lymphoma 58:12, pages 2824-2832.
Read now
Read now
Venera Kuci, Lena Nordström, Mats Jerkeman & Sara Ek. (2015) Emerging role of SOX11 in mantle cell lymphoma. Blood and Lymphatic Cancer: Targets and Therapy 5, pages 35-42.
Read now
Read now
Ayse Salihoglu, Muhlis Cem Ar & Teoman Soysal. (2015) Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide. Expert Review of Hematology 8:6, pages 765-783.
Read now
Read now
Articles from other publishers (6)
Marina Lukas, Britta Velten, Leopold Sellner, Katarzyna Tomska, Jennifer Hüellein, Tatjana Walther, Lena Wagner, Carolin Muley, Bian Wu, Małgorzata Oleś, Sascha Dietrich, Alexander Jethwa, Hanibal Bohnenberger, Junyan Lu, Wolfgang Huber & Thorsten Zenz. (2020) Survey of ex vivo drug combination effects in chronic lymphocytic leukemia reveals synergistic drug effects and genetic dependencies. Leukemia 34:11, pages 2934-2950.
Crossref
Crossref
Tamar Tadmor, Irena Liphshitz, Barbara Silverman & Aaron Polliack. (2017) Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up. Hematological Oncology 35:4, pages 599-607.
Crossref
Crossref
Jingjing Chen, Ming Yan & Lin Xu. (2017) Efficient synthesis of (S)-N-Boc-3-hydroxypiperidine using an (R)-specific carbonyl reductase from Candida parapsilosis. World Journal of Microbiology and Biotechnology 33:3.
Crossref
Crossref
Aurore Dougé, Aurélie Ravinet, Jacques-Olivier Bay, Olivier Tournilhac, Romain Guièze & Richard Lemal. (2016) Rationnel et modalités de prescription de l’ibrutinib dans les hémopathies lymphoïdes B. Bulletin du Cancer 103:2, pages 127-137.
Crossref
Crossref
Davide Grisafi, Alessandra Maestro, Camilla Grumi, Ludovica Piazzoni, Giampaolo Tirone, Walter Fiore, Roberto Tessari, Valeria Gianardi, Milo Gatti, Francesca Tasca, Daniele Generali, Andrea Ravelli, Francesco Lanza & Francesco Scaglione. (2015) Ibrutinib: from bench side to clinical implications. Medical Oncology 32:9.
Crossref
Crossref
Stanley C Jordan, Jua Choi & Ashley Vo. (2015) Achieving incompatible transplantation through desensitization: current perspectives and future directions. Immunotherapy 7:4, pages 377-398.
Crossref
Crossref